ReviewInternational journal of clinical pediatric dentistry2025
Emerging Paradigms in Preventive Dentistry: A Review of Nonfluoridated Remineralizing Agents.
Review in International journal of clinical pediatric dentistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fluoride-Free Toothpastes for Caries Prevention: A Systematic Review of Clinical Evidence on Active Ingredients.Clinical, cosmetic and investigational dentistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nonfluoridated remineralizing agents have gained significant attention as alternatives or adjuncts to fluoride for managing early caries and enhancing enamel health. This narrative review explores the composition, mechanisms of action, applications, and efficacy of various nonfluoridated remineralizing agents, including calcium phosphate-based systems, casein phosphopeptide-amorphous calcium phosphate (CPP-ACP), bioactive glass, hydroxyapatite nanoparticles, Galla Chinensis, theobromine, Enamelon technology, bamboo salt solution, grape seed extract, tricalcium phosphate, and titanium fluoride technology. The review is based on recent literature to provide a comprehensive overview of these materials and their clinical implications. Background: Dental caries remains one of the most prevalent oral diseases worldwide. Fluoride has been the cornerstone of caries prevention due to its well-documented ability to enhance enamel remineralization and inhibit demineralization. However, fluoride is often described as a double-edged sword. While its benefits in caries prevention are well-established, excessive fluoride exposure can lead to adverse effects such as dental fluorosis, enamel mottling, and systemic toxicity. These concerns are especially significant for young children, who are more vulnerable to fluoride ingestion. Consequently, there is a growing need to explore nonfluoridated remineralizing agents that can offer comparable efficacy without associated risks. Methods: A comprehensive literature search was conducted using databases such as PubMed, Scopus, and Web of Science. The search included studies published between 2015 and 2024 to ensure the inclusion of recent advancements. Keywords such as "nonfluoridated remineralizing agents," "enamel remineralization," "CPP-ACP," "bioactive glass," "hydroxyapatite," "Galla Chinensis," "theobromine," "Enamelon technology," "bamboo salt solution," "grape seed extract," "tricalcium phosphate," and "titanium fluoride" were used. Articles were selected based on relevance, with emphasis on randomized controlled trials, Results: This review examines recent advancements in nonfluoridated remineralizing agents, their mechanisms of action, and their role in contemporary preventive dentistry. Evidence suggests that nonfluoridated agents play a promising role in promoting enamel remineralization and reducing demineralization without the concerns associated with fluoride toxicity. Further research is warranted to refine these technologies and establish long-term clinical outcomes. How to cite this article: Thomas NA, Thimmaiah C, Shinu BR,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.